Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:57 PM
Ignite Modification Date:
2025-12-25 @ 12:45 PM
NCT ID:
NCT04603495
Group ID:
EG001
Title:
Placebo + Ruxolitinib (Control Arm)
Description:
Matching placebo orally (PO) once daily (QD) + ruxolitinib 10 or 15 mg orally (PO) twice a day (BID) for 14 consecutive days followed by ruxolitinib 10 or 15 mg orally (PO) twice a day (BID) for 7 days in a 21-day cycle
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
63
Serious Number At Risk:
214
Other Number Affected:
204
Other Number At Risk:
214
Study:
NCT04603495
Results Section:
NCT04603495
Adverse Events Module:
NCT04603495